The Effectiveness of Long-Term Treatment of Malignant Hypertension

Author:

DUSTAN HARRIET P.1,SCHNECKLOTH ROLAND E.1,CORCORAN A. C.1,PAGE IRVINE H.1

Affiliation:

1. From the Research Division of The Cleveland Clinic Foundation, and The Frank E. Bunts Educational Institute, Cleveland, Ohio.

Abstract

A survey is reported of the courses of 84 patients who presented the syndrome of malignant hypertension and who have been under treatment with potent antihypertensive drugs. Among these, 70 per cent survived 1 year of observation, 50 per cent 3 years, 33 per cent 5 years, and 26 per cent 6 years. These survival rates represent substantial therapeutic gains over survival rates in the untreated series of Keith, Wagener, and Barker. The reported first-year survival rate is weighted by the untoward complication of hexamethonium pneumonitis, and current survival is greater than in the estimate presented. Other causes of death are (1) rapidly or (2) delayed or slowly progressive renal failure and (3) complications of atherosclerosis. The first is usually associated with poor control of blood pressure. It seems merely an attenuation of the usual course of malignant hypertension. The syndrome of delayed or slowly progressive renal failure is associated with diffuse occlusive fibrous intimal hyperplasia of major renal arteries. Among the complications of atherosclerosis, cerebral hemorrhage was the most common and was associated with poor control of blood pressure level, while myocardial infarction, the next most common, was not. It may be that the coronary arteries, like the renal, are subject to progressive occlusive disease in some patients with treated malignant hypertension. It is not clear whether this process represents a continuation in vessels larger than arterioles, of a basic vascular disease or a delayed response on the part of the arteries to preexisting severe hypertension. Survival is improved in patients who undertake treatment before malignant hypertension has caused extensive vascular damage. Patients who present themselves for treatment with evidences of severe renal damage generally do not survive for long periods. However, several such have maintained active lives for many months and years. Hence treatment should be withheld only in the most desperate circumstances.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference9 articles.

1. DUBLIN L.. I. LOTKA A. J. AND SPIEGELMAN M.: Length of Life a Study of the Life Table. Ed. 2 New York Ronald Press 1949 pp. 178 179 180.

2. BECHGAARD P. KoPP H. AND NIELSEN J.: One thousand hypertensive patients followed from 16-22 years. Acta med. scandinav.

3. KEITH N. M. WAGENER H. P. AN1) BARKER Suppl. 312: 175 1956. N. W.: Sone different types of essential hypertension. Their course and prognosis. Amin. J. M. Se. 197: 332 1939.

4. PAGE I. 11.: -A clinical study of malignant

5. The hypertension;SCHOTTSTAEDT M. F.;Aknn. Int. Med.,1939

Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Oral Manifestations of Patients Taking Anti-Hypertensive Medications;Journal of Islamic Dental Association of IRAN;2020-10-01

2. History of Prehypertension: Past and Present, a Saga of Misunderstanding and Neglect;Updates in Hypertension and Cardiovascular Protection;2018-12-07

3. Guidelines for the Management of Hypertension;Medical Clinics of North America;2017-01

4. Malignant Hypertension: Clinical Manifestations of 7 Cases;Klinische Monatsblätter für Augenheilkunde;2015-04-22

5. Basic Study Design;Fundamentals of Clinical Trials;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3